Effect of cyclosporine A on the tissue distribution and pharmacokinetics of etoposide

AHFS Drug Information

Gerald K. McEvoy · Oncology Issues · 1994 · 892 citations

Preclinical Therapeutics, Therapeutic Guidelines, Pharmacotherapy +22

Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance.

B L Lum, Sonja Kaubisch, Alan M. Yahanda et al. · Journal of Clinical Oncology · 1992 · 298 citations

Therapeutic Drug Monitoring, Oncology, Medicine +12

Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance.

Alan M. Yahanda, K M Alder, George A. Fisher et al. · Journal of Clinical Oncology · 1992 · 218 citations

MDR Expression in Normal Tissues: Pharmocologic Implication for the Clinical Use of P-Glycoprotein Inhibitors

Bert L. Lum, Michael P. Gosland · Hematology/Oncology Clinics of North America · 1995 · 131 citations

Pharmacologic approaches to reversing multidrug resistance.

Branimir I. Šikić · PubMed · 1997 · 118 citations